Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Jan;51(1):37–48. doi: 10.1038/bjc.1985.6

"Concomitant immunity" in murine tumours of non-detectable immunogenicity.

R A Ruggiero, O D Bustuoabad, R D Bonfil, R P Meiss, C D Pasqualini
PMCID: PMC1976815  PMID: 2981538

Abstract

Various immunization assays were used to demonstrate the lack of immunogenicity of three BALB/c tumours of spontaneous origin and of a fourth one resulting from foreign body tumorigenesis. All four tumours inhibited the growth of a second implant of the same tumour into the contralateral flank. In our tumour models "concomitant immunity" (1) was not mediated by macrophage or T-cell dependent immune reactions: both thymectomized BALB/c and nude mice (treated or untreated with silica) gave the same results as intact mice; (2) showed some degree of non-specificity, inhibiting the growth of a different tumour in 3/4 cases; though, the existence of a specific component could not be discarded; (3) was proportional to the volume of the primary tumour at the time of the second challenge; (4) was dependent on actively growing primary tumour, not being obtained with progressively increasing daily inocula of irradiated tumour cells; (5) was detectable in an actively growing secondary tumour; recurrent growth after partial surgical excision was inhibited and (6) involved cytostasis of the secondary tumour: a syngeneic graft of the overlying skin led to tumour growth while histological studies revealed the presence of viable tumour cells. It is postulated that "concomitant immunity" or resistance can be generated without the active participation of the immune system and that tumour-related factors are, in certain cases, responsible for blocking the growth of secondary tumours.

Full text

PDF
40

Images in this article

46Figure 5
on p.46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Harington J. S., Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med. 1966 Aug 1;124(2):141–154. doi: 10.1084/jem.124.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Attia M. A., Weiss D. W. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res. 1966 Aug;26(8):1787–1800. [PubMed] [Google Scholar]
  3. BIOZZI G., BENACERRAF B., HALPERN B. N. Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity. Br J Exp Pathol. 1953 Aug;34(4):441–457. [PMC free article] [PubMed] [Google Scholar]
  4. Crile G., Jr, Deodhar S. D. Role of preoperative irradiation in prolonging concomitant immunity and preventing metastasis in mice. Cancer. 1971 Mar;27(3):629–634. doi: 10.1002/1097-0142(197103)27:3<629::aid-cncr2820270318>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  5. Deckers P. J., Davis R. C., Parker G. A., Mannick J. A. The effect of tumor size on concomitant tumor immunity. Cancer Res. 1973 Jan;33(1):33–39. [PubMed] [Google Scholar]
  6. Djeu J. Y., Heinbaugh J. A., Vieira W. D., Holden H. T., Herberman R. B. The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I:C. Immunopharmacology. 1979 Jun;1(3):231–244. doi: 10.1016/0162-3109(79)90040-7. [DOI] [PubMed] [Google Scholar]
  7. Gorelik E. Concomitant tumor immunity and the resistance to a second tumor challenge. Adv Cancer Res. 1983;39:71–120. doi: 10.1016/s0065-230x(08)61033-7. [DOI] [PubMed] [Google Scholar]
  8. Gorelik E. Resistance of tumor-bearing mice to a second tumor challenge. Cancer Res. 1983 Jan;43(1):138–145. [PubMed] [Google Scholar]
  9. Gorelik E., Segal S., Feldman M. On the mechanism of tumor "concomitant immunity". Int J Cancer. 1981 Jun 15;27(6):847–856. doi: 10.1002/ijc.2910270618. [DOI] [PubMed] [Google Scholar]
  10. Hewitt H. B., Blake E. R., Walder A. S. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer. 1976 Mar;33(3):241–259. doi: 10.1038/bjc.1976.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hewitt H. B. The choice of animal tumors for experimental studies of cancer therapy. Adv Cancer Res. 1978;27:149–200. doi: 10.1016/s0065-230x(08)60932-x. [DOI] [PubMed] [Google Scholar]
  12. Kearney R., Nelson D. S. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity. Aust J Exp Biol Med Sci. 1973 Dec;51(6):723–735. doi: 10.1038/icb.1973.70. [DOI] [PubMed] [Google Scholar]
  13. Levy M. H., Wheelock E. F. Effects of intravenous silica on immune and non-immune functions of the murine host. J Immunol. 1975 Jul;115(1):41–48. [PubMed] [Google Scholar]
  14. Middle J. G., Embleton M. J. Naturally arising tumors of the inbred WAB/Not rat strain. II. Immunogenicity of transplanted tumors. J Natl Cancer Inst. 1981 Sep;67(3):637–643. [PubMed] [Google Scholar]
  15. North R. J., Kirstein D. P. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites. J Exp Med. 1977 Feb 1;145(2):275–292. doi: 10.1084/jem.145.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pasqualini C. D., Sen L., Saal F., Schwartz L., Tkaczevski L. Z. Tumor development in mice bearing a plastic cylinder and inoculated with human neoplastic cells. J Natl Cancer Inst. 1973 Jul;51(1):283–286. doi: 10.1093/jnci/51.1.283. [DOI] [PubMed] [Google Scholar]
  17. Southam C. M. Co-existence of allogeneic tumour growth and homograft immunity in man. Eur J Cancer. 1968 Oct;4(5):507–511. doi: 10.1016/0014-2964(68)90006-6. [DOI] [PubMed] [Google Scholar]
  18. Vaage J. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue. Cancer Res. 1971 Nov;31(11):1655–1662. [PubMed] [Google Scholar]
  19. WINN H. J. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol. 1961 Feb;86:228–239. [PubMed] [Google Scholar]
  20. Yuhas J. M., Pazmiño N. H., Wagner E. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma. Cancer Res. 1975 Jan;35(1):237–241. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES